Cue Health Inc.: Nasdaq/NYSE listing notice — Cue Health receives Nasdaq deficiency notice for bid price below $1/share

Cue Health Inc.

Received Nasdaq notice on June 6, 2023 for failing minimum $1 bid price over 30 consecutive business days.
Has 180 days, until Dec 4, 2023, to regain compliance by closing at $1+ for 10 consecutive days.
May transfer to Nasdaq Capital Market for an additional 180-day cure period if needed.
Considering options including reverse stock split to cure the deficiency.
No immediate delisting; but risk of delisting if compliance not achieved.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Cue Health Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)

Exact text from the filing

June 6, 2023, Cue Health Inc. (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company did not satisfy the requirement for continued listing on the Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a) (“Rule 5450(a)”) to maintain a minimum bid price of $1 per share. The Company became deficient with Rule 5450(a) as of June 6, 2023 as its closing bid price was less than $1 per share for 30 consecutive business days prior to the date of the Notice. The Notice is a notice of

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001628945-23-000127

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.